Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
PACBIO REAGENT KITS. ALL REAGENTS FOR SEQUENCING 24 REVIO SMRT CELLS QUANTITY 8, AND ASSOCIATED LIBRARY PREP REAGENTS. is a federal award for Usda Ars Afm Apd held by Pacific Biosciences of California, Inc. Estimated value $233K ($233K obligated). Current period of performance ends Sep 30, 2026. Place of performance: MENLO PARK CA.
PACBIO REAGENT KITS. ALL REAGENTS FOR SEQUENCING 24 REVIO SMRT CELLS QUANTITY 8, AND ASSOCIATED LIBRARY PREP REAGENTS.
Recompete timing
PublicCurrent PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordPacific Biosciences of California, Inc — $7.8M obligated across 81 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 1232SA25F0277?
1232SA25F0277 (PACBIO reagent KITS. ALL reagents for) is a Usda Ars Afm Apd award with a potential value of $233K, currently held by Pacific Biosciences of California, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 1232SA-25-F-0277?
1232SA-25-F-0277 is the dashed form of PIID 1232SA25F0277 (PACBIO reagent KITS. ALL reagents for), held by Pacific Biosciences of California, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 1232SA25F0277?
Usda Ars Afm Apd awarded 1232SA25F0277 to Pacific Biosciences of California, Inc (potential $233K).
Who is the incumbent on 1232SA25F0277?
Pacific Biosciences of California, Inc is the incumbent with $7.8M across 81 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.
When does Pacific Biosciences of California, Inc’s 1232SA25F0277 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.